Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 19 | $1,071,394 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 120 | 149.03 | 17,884 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 518 | 148.24 | 76,788 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 369 | 147.5 | 54,428 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 944 | 186.39 | 175,952 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 1,593 | 185.54 | 295,565 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 658 | 184.7 | 121,533 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 68 | 197.08 | 13,401 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 42 | 195.65 | 8,217 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 414 | 194.94 | 80,705 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 372 | 193.93 | 72,142 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 81 | 193.18 | 15,648 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)